NO20026154L - Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number: NO20026154L
Authority: NO; Norway
Prior art keywords: preparation; methods; pharmaceutical compositions; compositions containing; new substituted
Prior art date: 2000-06-28

Application number

NO20026154A

Other languages

English (en)

Other versions

NO20026154D0 (no

Inventor

Zongru Guo

Fengming Chu

Juntian Zhang

Guangzhong Yang

Bailing Xu

Xinyi Niu

Zhihong Ren

Pierre Lestage

Pierre Renard

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-28

Filing date

2002-12-20

Publication date

2003-02-20

2002-12-20 Application filed by Servier Lab filed Critical Servier Lab

2002-12-20 Publication of NO20026154D0 publication Critical patent/NO20026154D0/no

2003-02-20 Publication of NO20026154L publication Critical patent/NO20026154L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Psychology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20026154A 2000-06-28 2002-12-20 Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem NO20026154L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CNB001193295A CN1182127C (zh)	2000-06-28	2000-06-28	新的取代的2-苯并[c]呋喃酮化合物,其制备方法以及包含它们的药物组合物
PCT/IB2001/001535 WO2002000638A2 (en)	2000-06-28	2001-06-27	Substituted phthalides as anti-convulsive drugs

Publications (2)

Publication Number	Publication Date
NO20026154D0 NO20026154D0 (no)	2002-12-20
NO20026154L true NO20026154L (no)	2003-02-20

Family

ID=4587601

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20026154A NO20026154L (no)	2000-06-28	2002-12-20	Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Country Status (19)

Country	Link
US (1)	US6689808B2 (no)
EP (1)	EP1320528A2 (no)
JP (1)	JP2004501909A (no)
KR (1)	KR20030024710A (no)
CN (2)	CN1182127C (no)
AR (1)	AR030239A1 (no)
AU (1)	AU2001280004A1 (no)
BR (1)	BR0112043A (no)
CA (1)	CA2413752A1 (no)
CZ (1)	CZ2003245A3 (no)
EA (1)	EA200300044A1 (no)
HU (1)	HUP0301567A3 (no)
MX (1)	MXPA02012569A (no)
NO (1)	NO20026154L (no)
NZ (1)	NZ523174A (no)
PL (1)	PL359373A1 (no)
SK (1)	SK1062003A3 (no)
WO (1)	WO2002000638A2 (no)
ZA (1)	ZA200210004B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1622605B1 (en)	2003-05-14	2009-07-15	DSM IP Assets B.V.	Use of phthalide derivatives for the treatment and prevention of diabetes mellitus
KR20060121887A (ko)	2003-09-23	2006-11-29	디에스엠 아이피 어셋츠 비.브이.	진성 당뇨병의 치료 및 예방용 조성물
CN1605336A (zh)	2003-10-10	2005-04-13	中国医学科学院药物研究所	左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用
JP2008502607A (ja) *	2004-06-18	2008-01-31	石薬集団中奇制薬技術（石家庄）有限公司	痴呆の予防および治療におけるＬ−ｎ−ブチルフタリドの適用
CN106074497A (zh) *	2010-01-13	2016-11-09	石药集团恩必普药业有限公司	丁苯酞及其衍生物在制备治疗帕金森病的药物中的应用
CN102260233A (zh) *	2011-05-04	2011-11-30	武汉科技大学	3-丁基-1(3h)-异苯并呋喃酮衍生物及其制备方法
CN105367526B (zh) *	2015-10-14	2017-07-28	济南诚汇双达化工有限公司	一种高纯度正丁基苯酞的制备方法
CN108727352B (zh) *	2017-04-14	2021-04-23	四川大学	一类哌啶烷氨甲酰基苯酞类化合物、其制备方法和用途
PT3845524T (pt) *	2018-03-19	2022-09-28	Henan Genuine Biotech Co Ltd	Compostos de ácido benzoico e método de preparação destes e suas aplicações
CN108752300B (zh) *	2018-05-16	2022-03-25	中国科学院昆明植物研究所	苄烯叉苯肽类化合物及其药物组合物和其应用
CN109111415B (zh) *	2018-10-25	2022-08-23	安徽中医药大学	一类石斛生物碱衍生物、制备方法和医药用途
CN112010837B (zh) *	2019-05-28	2021-12-17	四川大学	一类吡啶甲胺基苯酞类化合物、其制备方法和用途
CN112010827A (zh) *	2019-05-28	2020-12-01	四川大学	一类苄胺基苯酞类化合物、其制备方法和用途
CN110452203B (zh) *	2019-08-29	2021-04-13	忻州师范学院	一种1-氧代-1,3-二氢-3-羟基苯并呋喃-5-甲酸的制备方法
CN112794831B (zh) *	2021-04-06	2021-07-27	北京理工大学	3-(3′-羟基丁基)异苯并呋喃-1(3h)-酮衍生物及其组合物、制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1183053B (it) *	1984-02-02	1987-10-05	Farmaceutico Ct Lab	Derivati dell'alfa-amino-gamma-butirrolatton e, metodo per prepararli e composizioni farmaceutiche che li contengono
DE3615157A1 (de) *	1986-05-05	1987-11-12	Schwabe Willmar Gmbh & Co	5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe
CA1330613C (en) *	1988-05-06	1994-07-05	Masanori Kawamura	Amino acid derivatives
TW270133B (no) *	1993-09-17	1996-02-11	Ciba Geigy
DE19618854A1 (de) *	1996-05-10	1997-11-13	Basf Ag	Verfahren zur Herstellung von Phthaliden
DE19626659A1 (de) *	1996-07-03	1998-01-08	Basf Ag	Verfahren zur Herstellung von Phthaliden

2000
- 2000-06-28 CN CNB001193295A patent/CN1182127C/zh not_active Expired - Fee Related
2001
- 2001-06-27 SK SK106-2003A patent/SK1062003A3/sk unknown
- 2001-06-27 CN CNB018120687A patent/CN100402515C/zh not_active Expired - Fee Related
- 2001-06-27 JP JP2002505386A patent/JP2004501909A/ja active Pending
- 2001-06-27 CA CA002413752A patent/CA2413752A1/en not_active Abandoned
- 2001-06-27 AU AU2001280004A patent/AU2001280004A1/en not_active Abandoned
- 2001-06-27 AR ARP010103051A patent/AR030239A1/es not_active Application Discontinuation
- 2001-06-27 HU HU0301567A patent/HUP0301567A3/hu unknown
- 2001-06-27 NZ NZ523174A patent/NZ523174A/en unknown
- 2001-06-27 KR KR1020027017839A patent/KR20030024710A/ko not_active Application Discontinuation
- 2001-06-27 PL PL01359373A patent/PL359373A1/xx not_active Application Discontinuation
- 2001-06-27 CZ CZ2003245A patent/CZ2003245A3/cs unknown
- 2001-06-27 EP EP01958282A patent/EP1320528A2/en not_active Withdrawn
- 2001-06-27 MX MXPA02012569A patent/MXPA02012569A/es unknown
- 2001-06-27 WO PCT/IB2001/001535 patent/WO2002000638A2/en not_active Application Discontinuation
- 2001-06-27 US US10/312,650 patent/US6689808B2/en not_active Expired - Fee Related
- 2001-06-27 BR BR0112043-3A patent/BR0112043A/pt not_active IP Right Cessation
- 2001-06-27 EA EA200300044A patent/EA200300044A1/ru unknown
2002
- 2002-12-10 ZA ZA200210004A patent/ZA200210004B/en unknown
- 2002-12-20 NO NO20026154A patent/NO20026154L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2004501909A (ja)	2004-01-22
CZ2003245A3 (cs)	2003-05-14
BR0112043A (pt)	2003-10-28
WO2002000638A3 (en)	2002-05-23
CA2413752A1 (en)	2002-01-03
EA200300044A1 (ru)	2003-06-26
WO2002000638A2 (en)	2002-01-03
CN1182127C (zh)	2004-12-29
ZA200210004B (en)	2003-12-10
MXPA02012569A (es)	2004-05-17
NO20026154D0 (no)	2002-12-20
US6689808B2 (en)	2004-02-10
CN100402515C (zh)	2008-07-16
CN1330069A (zh)	2002-01-09
KR20030024710A (ko)	2003-03-26
WO2002000638A8 (en)	2003-08-28
US20030220393A1 (en)	2003-11-27
SK1062003A3 (en)	2003-05-02
EP1320528A2 (en)	2003-06-25
NZ523174A (en)	2004-06-25
PL359373A1 (en)	2004-08-23
AU2001280004A1 (en)	2002-01-08
HUP0301567A3 (en)	2005-08-29
HUP0301567A2 (hu)	2003-09-29
CN1440398A (zh)	2003-09-03
AR030239A1 (es)	2003-08-13

Similar Documents

Publication	Publication Date	Title
DK1263721T3 (da)	2011-01-03	Farmaceutiske sammensætninger, der indeholder 3-aminoazetidinderivater, nye derivater og fremstilling deraf
EE200300054A (et)	2004-12-15	Kinaasi inhibiitoritena toimivad bitsüklopürasoolid, nende valmistamismeetod, kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
NO20013254L (no)	2001-12-31	Nye difenylureaforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske samensetninger som inneholder dem
NO996250D0 (no)	1999-12-16	Nye hydrazidforbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
NO20042805L (no)	2004-07-02	Nye forbindelser og deres anvendelse innen medisin, fremgangsmate for deres fremstilling og farmaoytiske sammensetninger som inneholder dem
NO20014102L (no)	2001-10-24	Nye tricykliske forbindelser og deres anvendelse innenfor medisin, fremgangsmåte for deres fremstilling og farmasöytisksammensetning som inneholder dem
NO20026154L (no)	2003-02-20	Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20052683D0 (no)	2005-06-03	Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20010522L (no)	2001-08-01	Nye piperidin-4-sulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20014945L (no)	2002-04-15	Nye cyklonbutendionforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20031643L (no)	2003-04-10	Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20010305D0 (no)	2001-01-18	Nye benzensulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021330L (no)	2002-09-20	Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20013710D0 (no)	2001-07-27	Nye benzotiadiazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021198L (no)	2002-09-13	Nye isoindoloindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20035215D0 (no)	2003-11-24	Tricykliske dihydrokinolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023389D0 (no)	2002-07-12	Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20041313L (no)	2004-10-11	Nye isokinolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20016069L (no)	2002-06-17	Nye bicykliske amino-pyrazinonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20023409D0 (no)	2002-07-15	Nye N-benzylpiperazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20026004L (no)	2002-12-13	Nye podofyllotoksinkarbamat- og tiokarbamatforbindelser, fremgangsmåte vedderes fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20021806D0 (no)	2002-04-17	Nye pyrimidin-4-on-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20022794L (no)	2002-12-16	Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20011862L (no)	2001-10-15	Nye heterocykloalkylbenzocyklobutan- og heteroarylbenzocyklobutanforbindelser, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem
NO20043880L (no)	2005-03-17	Nye benzoindolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Legal Events

Date	Code	Title	Description
2005-05-09	FC2A	Withdrawal, rejection or dismissal of laid open patent application